Resmed Inc. <RMD.N>: Wells Fargo Cuts Target Price to $215 From $225
RMD•Related News
Gold set for best week since January as inflation fears ebb
GLD•
DaVita Inc cuts target price to $215 from $250
DVA•
Plains All American keeps 2026 adjusted EBITDA outlook at $2.88 billion +/- $75 million
PAA•
Praxis Precision Medicines, Inc. <PRAX.O>: Wedbush Raises Target Price to $188 From $162
PRAX•
Plains All American Q2 FY26 net income attributable to PAA swings to profit of $1.83 billion; revenue rises to $17.69 billion
PAA•